Map2k1 | Rat | (+)-catechin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Catechin results in decreased expression of MAP2K1 mRNA; Catechin results in decreased expression of MAP2K1 more ... | CTD | PMID:15465739 |
Map2k1 | Rat | (+)-catechin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:21882252 |
Map2k1 | Rat | (+)-catechin | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Catechin results in increased expression of MAP2K1 mRNA | CTD | PMID:15465739 |
Map2k1 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP2K1 mRNA] | CTD | PMID:31150632 |
Map2k1 | Rat | (20R)-protopanaxadiol | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | protopanaxadiol results in increased expression of MAP2K1 mRNA | CTD | PMID:31805304 |
Map2k1 | Rat | (Z)-PUGNAc | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:23029544 |
Map2k1 | Rat | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of MAP2K1 mRNA | CTD | PMID:25575267 |
Map2k1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP2K1 mRNA | CTD | PMID:22206623 |
Map2k1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MAP2K1 mRNA | CTD | PMID:22206623 |
Map2k1 | Rat | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine co-treated with TNF protein] results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:14654170 |
Map2k1 | Rat | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | decreases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:14654170 |
Map2k1 | Rat | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile | increases expression | EXP | | 6480464 | Citalopram results in increased expression of MAP2K1 mRNA | CTD | PMID:28467792 |
Map2k1 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Map2k1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of MAP2K1 mRNA | CTD | PMID:17555576 |
Map2k1 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of MAP2K1 mRNA | CTD | PMID:17108234 |
Map2k1 | Rat | 17beta-estradiol | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of MAP2K1 mRNA] | CTD | PMID:25210133 |
Map2k1 | Rat | 17beta-estradiol | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | IGF1R mutant form inhibits the reaction [Estradiol results in increased expression of MAP2K1 mRNA] | CTD | PMID:23094148 |
Map2k1 | Rat | 17beta-estradiol | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049|PMID:23094148 |
Map2k1 | Rat | 17beta-estradiol | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Estradiol affects the expression of MAP2K1 mRNA | CTD | PMID:22574217 |
Map2k1 | Rat | 17beta-estradiol | affects expression | ISO | Map2k1 (Mus musculus) | 6480464 | Estradiol affects the expression of MAP2K1 mRNA | CTD | PMID:15598610 |
Map2k1 | Rat | 17beta-estradiol | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | Estradiol results in increased activity of MAP2K1 protein | CTD | PMID:15615701 |
Map2k1 | Rat | 17beta-estradiol | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Estradiol results in increased expression of MAP2K1 mRNA | CTD | PMID:14664709|PMID:25210133|PMID:25575267 |
Map2k1 | Rat | 17beta-estradiol 3-benzoate | decreases phosphorylation | EXP | | 6480464 | estradiol 3-benzoate results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:15778002 |
Map2k1 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity more ... | CTD | PMID:15466214 |
Map2k1 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MAP2K1 protein | CTD | PMID:31675489 |
Map2k1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased activity of MAP2K1 protein | CTD | PMID:15313166 |
Map2k1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Map2k1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP2K1 mRNA | CTD | PMID:21570461 |
Map2k1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein modified form binds to more ... | CTD | PMID:12213569|PMID:12758056|PMID:20450880 |
Map2k1 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of MAP2K1 mRNA | CTD | PMID:31675489 |
Map2k1 | Rat | 2,5-dimethylcelecoxib | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2,5-dimethylcelecoxib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:16123214 |
Map2k1 | Rat | 2,5-dimethylcelecoxib | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2,5-dimethylcelecoxib inhibits the reaction [IL6 protein results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:16123214 |
Map2k1 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of MAP2K1 mRNA | CTD | PMID:21346803 |
Map2k1 | Rat | 2-aminobiphenyl | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein promotes the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein] | CTD | PMID:22288910 |
Map2k1 | Rat | 2-arachidonoylglycerol | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased more ... | CTD | PMID:12657697 |
Map2k1 | Rat | 2-methylcholine | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of MAP2K1 mRNA | CTD | PMID:21179406 |
Map2k1 | Rat | 3',5'-cyclic GMP | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cyclic GMP affects the reaction [NPPA protein alternative form results in decreased phosphorylation of and more ... | CTD | PMID:18225537 |
Map2k1 | Rat | 3',5'-cyclic GMP | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cyclic GMP results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:18225537 |
Map2k1 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of MAP2K1 protein | CTD | PMID:31675489 |
Map2k1 | Rat | 3,7-dihydropurine-6-thione | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Mercaptopurine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
Map2k1 | Rat | 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in more ... | CTD | PMID:11861786 |
Map2k1 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [FSHB protein co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [Testosterone promotes the reaction [RAF1 results in more ... | CTD | PMID:21177760 |
Map2k1 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased phosphorylation of MAP2K1 protein; alisol B promotes the more ... | CTD | PMID:28051915 |
Map2k1 | Rat | 3-methylcholanthrene | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of MAP2K1 mRNA | CTD | PMID:25926378 |
Map2k1 | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of MAP2K1 mRNA | CTD | PMID:19162173 |
Map2k1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of MAP2K1 protein | CTD | PMID:34186270 |
Map2k1 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein; Catechin inhibits the reaction more ... | CTD | PMID:21882252 |
Map2k1 | Rat | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | decreases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:14654170 |
Map2k1 | Rat | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine co-treated with TNF protein] results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:14654170 |
Map2k1 | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Decitabine results in increased expression of MAP2K1 mRNA | CTD | PMID:17785578 |
Map2k1 | Rat | 5-fluorouracil | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [U 0126 results in decreased activity of MAP2K1 protein] results in increased susceptibility to [Fluorouracil more ... | CTD | PMID:21444628 |
Map2k1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MAP2K1 mRNA | CTD | PMID:30047161 |
Map2k1 | Rat | 9-cis,11-trans-octadecadienoic acid | multiple interactions | EXP | | 6480464 | [cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and more ... | CTD | PMID:17869086 |
Map2k1 | Rat | acetylsalicylic acid | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Aspirin results in increased expression of MAP2K1 mRNA | CTD | PMID:20457246 |
Map2k1 | Rat | acrolein | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 |
Map2k1 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of MAP2K1 mRNA | CTD | PMID:28959563 |
Map2k1 | Rat | adenosine | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Adenosine results in increased phosphorylation of MAP2K1 protein | CTD | PMID:34070360 |
Map2k1 | Rat | afimoxifene | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | afimoxifene results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049 |
Map2k1 | Rat | aflatoxin B1 | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of MAP2K1 mRNA | CTD | PMID:27153756|PMID:34396909 |
Map2k1 | Rat | aflatoxin B1 | increases methylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MAP2K1 intron | CTD | PMID:30157460 |
Map2k1 | Rat | Alisol B | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | alisol B promotes the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased phosphorylation of MAP2K1 more ... | CTD | PMID:28051915 |
Map2k1 | Rat | all-trans-retinoic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [arsenic trioxide promotes the reaction [Tretinoin results in increased phosphorylation of more ... | CTD | PMID:18098270|PMID:20615082 |
Map2k1 | Rat | all-trans-retinoic acid | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Tretinoin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19038232 |
Map2k1 | Rat | all-trans-retinoic acid | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MAP2K1 protein | CTD | PMID:18098270 |
Map2k1 | Rat | all-trans-retinol | multiple interactions | EXP | | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein]; AG more ... | CTD | PMID:16510265 |
Map2k1 | Rat | all-trans-retinol | increases phosphorylation | EXP | | 6480464 | Vitamin A results in increased phosphorylation of MAP2K1 protein | CTD | PMID:16510265 |
Map2k1 | Rat | alpha-mangostin | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | mangostin analog results in increased phosphorylation of MAP2K1 protein | CTD | PMID:28722351 |
Map2k1 | Rat | alpha-pinene | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 |
Map2k1 | Rat | amiodarone | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | MAP2K1 protein inhibits the reaction [Amiodarone results in decreased expression of SNAI1 protein] | CTD | PMID:26515726 |
Map2k1 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of MAP2K1 mRNA | CTD | PMID:30047161 |
Map2k1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MAP2K1 mRNA | CTD | PMID:16483693 |
Map2k1 | Rat | ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:12420312 |
Map2k1 | Rat | Ammothamnine | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [oxymatrine results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein more ... | CTD | PMID:39419199 |
Map2k1 | Rat | amsacrine | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [Amsacrine results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein more ... | CTD | PMID:37451322 |
Map2k1 | Rat | anandamide | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity more ... | CTD | PMID:12657697 |
Map2k1 | Rat | anethole | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein] | CTD | PMID:10871845 |
Map2k1 | Rat | anthranilic acid | decreases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | anthranilic acid results in decreased activity of MAP2K1 protein | CTD | PMID:18393446 |
Map2k1 | Rat | antimonite | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of more ... | CTD | PMID:32076005 |
Map2k1 | Rat | Antrocin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | antrocin analog results in decreased expression of MAP2K1 protein | CTD | PMID:36565974 |
Map2k1 | Rat | Antrocin | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | antrocin analog results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:36565974 |
Map2k1 | Rat | arachidonic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | FOS protein affects the reaction [MAP2K1 protein inhibits the reaction [Arachidonic Acid results in increased more ... | CTD | PMID:19720122 |
Map2k1 | Rat | Aroclor 1254 | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of MAP2K1 mRNA | CTD | PMID:23650126 |
Map2k1 | Rat | arsane | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 |
Map2k1 | Rat | arsenic acid | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | arsenic acid results in increased activity of MAP2K1 protein | CTD | PMID:14674888 |
Map2k1 | Rat | arsenic atom | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 |
Map2k1 | Rat | arsenite(3-) | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | arsenite results in increased activity of MAP2K1 protein | CTD | PMID:14674888 |
Map2k1 | Rat | arsenous acid | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MAP2K1 mRNA | CTD | PMID:22521957 |
Map2k1 | Rat | arsenous acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of more ... | CTD | PMID:20615082 |
Map2k1 | Rat | arsenous acid | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:20592496 |
Map2k1 | Rat | arsenous acid | decreases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:28454374 |
Map2k1 | Rat | arsenous acid | decreases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased activity of MAP2K1 protein | CTD | PMID:11304686 |
Map2k1 | Rat | ATP | affects binding | ISO | Map2k1 (Mus musculus) | 6480464 | Adenosine Triphosphate binds to MAP2K1 protein | CTD | PMID:17693661 |
Map2k1 | Rat | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of MAP2K1 mRNA | CTD | PMID:30580161 |
Map2k1 | Rat | azathioprine | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Azathioprine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
Map2k1 | Rat | benzo[a]pyrene | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MAP2K1 mRNA] | CTD | PMID:22228805 |
Map2k1 | Rat | benzo[a]pyrene | affects methylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MAP2K1 intron | CTD | PMID:30157460 |
Map2k1 | Rat | benzo[a]pyrene | increases methylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MAP2K1 promoter | CTD | PMID:27901495 |
Map2k1 | Rat | benzo[a]pyrene | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein; Catechin inhibits the reaction more ... | CTD | PMID:21882252 |
Map2k1 | Rat | benzo[a]pyrene | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MAP2K1 mRNA | CTD | PMID:22228805 |
Map2k1 | Rat | beryllium difluoride | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | beryllium fluoride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11867686 |
Map2k1 | Rat | bicalutamide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity more ... | CTD | PMID:15466214 |
Map2k1 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of MAP2K1 mRNA | CTD | PMID:18955075 |
Map2k1 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:35841924 |
Map2k1 | Rat | bis(2-ethylhexyl) phthalate | decreases phosphorylation | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:35841924 |
Map2k1 | Rat | bisphenol A | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MAP2K1 mRNA | CTD | PMID:25575267|PMID:33221593 |
Map2k1 | Rat | bisphenol A | decreases methylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MAP2K1 gene | CTD | PMID:31601247 |
Map2k1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MAP2K1 mRNA | CTD | PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585 |
Map2k1 | Rat | bisphenol A | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MAP2K1 mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:29275510|PMID:31675489 |
Map2k1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MAP2K1 mRNA | CTD | PMID:25181051 |
Map2k1 | Rat | bisphenol AF | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of MAP2K1 protein | CTD | PMID:34186270 |
Map2k1 | Rat | Bisphenol B | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of MAP2K1 protein | CTD | PMID:34186270 |
Map2k1 | Rat | bortezomib | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Bortezomib co-treated with Butyrates] results in decreased expression of MAP2K1 protein; [Bortezomib co-treated with vorinostat] more ... | CTD | PMID:12893773 |
Map2k1 | Rat | cadmium acetate | affects expression | EXP | | 6480464 | cadmium acetate affects the expression of MAP2K1 mRNA | CTD | PMID:16249259 |
Map2k1 | Rat | cadmium atom | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cadmium results in increased phosphorylation of MAP2K1 protein | CTD | PMID:14499349 |
Map2k1 | Rat | cadmium atom | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | GPER1 mutant form inhibits the reaction [Cadmium results in increased activity of MAP2K1 protein]; MAP2K1 more ... | CTD | PMID:20153348|PMID:25069788 |
Map2k1 | Rat | cadmium atom | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cadmium results in increased activity of MAP2K1 protein | CTD | PMID:20153348 |
Map2k1 | Rat | cadmium dichloride | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of more ... | CTD | PMID:11858940 |
Map2k1 | Rat | cadmium dichloride | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:32512071 |
Map2k1 | Rat | cadmium dichloride | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:18703135 |
Map2k1 | Rat | cadmium dichloride | increases phosphorylation | EXP | | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:18703135 |
Map2k1 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
Map2k1 | Rat | cadmium dichloride | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
Map2k1 | Rat | cadmium dichloride | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11858940 |
Map2k1 | Rat | calcium atom | multiple interactions | EXP | | 6480464 | [Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased more ... | CTD | PMID:12574409 |
Map2k1 | Rat | calcium(0) | multiple interactions | EXP | | 6480464 | [Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased more ... | CTD | PMID:12574409 |
Map2k1 | Rat | cannabidiol | affects methylation | EXP | | 6480464 | Cannabidiol affects the methylation of MAP2K1 gene | CTD | PMID:30521419 |
Map2k1 | Rat | cannabidiol | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cannabidiol co-treated with moringin] results in increased expression of MAP2K1 mRNA; [Oxygen co-treated with Ozone more ... | CTD | PMID:30096889|PMID:32992648 |
Map2k1 | Rat | cannabidiol | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of MAP2K1 mRNA | CTD | PMID:32992648 |
Map2k1 | Rat | capsaicin | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Capsaicin results in increased expression of MAP2K1 mRNA | CTD | PMID:19502594 |
Map2k1 | Rat | carbon nanotube | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of MAP2K1 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 |
Map2k1 | Rat | celecoxib | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Celecoxib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:16123214 |
Map2k1 | Rat | chenodeoxycholic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:32152650 |
Map2k1 | Rat | chloropicrin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of MAP2K1 mRNA | CTD | PMID:28476498 |
Map2k1 | Rat | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of MAP2K1 mRNA | CTD | PMID:18668222 |
Map2k1 | Rat | choline | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Choline inhibits the reaction [Sodium Fluoride results in decreased expression of MAP2K1 mRNA] | CTD | PMID:27664006 |
Map2k1 | Rat | choline | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Choline results in increased expression of MAP2K1 mRNA | CTD | PMID:27664006 |
Map2k1 | Rat | cisplatin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with Quercetin] results in increased expression of MAP2K1 mRNA; [U 0126 results in more ... | CTD | PMID:21444628|PMID:27514524 |
Map2k1 | Rat | cisplatin | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | MAP2K1 protein promotes the reaction [Cisplatin results in increased activity of CASP3 protein]; MAP2K1 protein more ... | CTD | PMID:20547441 |
Map2k1 | Rat | cisplatin | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cisplatin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:21444628 |
Map2k1 | Rat | citalopram | increases expression | EXP | | 6480464 | Citalopram results in increased expression of MAP2K1 mRNA | CTD | PMID:28467792 |
Map2k1 | Rat | clobetasol | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of MAP2K1 mRNA | CTD | PMID:27462272 |
Map2k1 | Rat | clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of MAP2K1 mRNA | CTD | PMID:15860345 |
Map2k1 | Rat | cobalt dichloride | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [cobaltous chloride results in more ... | CTD | PMID:14536030 |
Map2k1 | Rat | cobalt dichloride | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:19376846 |
Map2k1 | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:24386269 |
Map2k1 | Rat | cocaine | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cocaine results in decreased expression of MAP2K1 mRNA | CTD | PMID:12629581 |
Map2k1 | Rat | cocaine | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:15665076 |
Map2k1 | Rat | cocaine | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Cocaine results in increased phosphorylation of MAP2K1 protein | CTD | PMID:15665076 |
Map2k1 | Rat | colforsin daropate hydrochloride | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased phosphorylation of MAP2K1 protein; alisol B promotes the more ... | CTD | PMID:28051915 |
Map2k1 | Rat | copper atom | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of MAP2K1 mRNA | CTD | PMID:30911355 |
Map2k1 | Rat | copper(0) | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of MAP2K1 mRNA | CTD | PMID:30911355 |
Map2k1 | Rat | copper(II) chloride | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of MAP2K1 mRNA | CTD | PMID:38568856 |
Map2k1 | Rat | copper(II) sulfate | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of MAP2K1 mRNA | CTD | PMID:19549813 |
Map2k1 | Rat | copper(II) sulfate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Copper Sulfate results in increased phosphorylation of MAP2K1 protein]; Copper Sulfate more ... | CTD | PMID:10564177 |
Map2k1 | Rat | cordycepin | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | cordycepin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:34070360 |
Map2k1 | Rat | corn oil | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Corn Oil results in increased expression of MAP2K1 mRNA | CTD | PMID:33263755 |
Map2k1 | Rat | corticosterone | multiple interactions | EXP | | 6480464 | astragaloside VI inhibits the reaction [Corticosterone results in decreased expression of and results in decreased more ... | CTD | PMID:36559001 |
Map2k1 | Rat | crocidolite asbestos | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | MAP2K1 protein affects the reaction [Asbestos, Crocidolite results in increased expression of SCGB1A1 mRNA]; MAP2K1 more ... | CTD | PMID:18192500 |
Map2k1 | Rat | crocidolite asbestos | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Asbestos, Crocidolite affects the expression of MAP2K1 mRNA | CTD | PMID:24160326 |
Map2k1 | Rat | crocidolite asbestos | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in increased phosphorylation of MAP2K1 protein | CTD | PMID:18314537 |
Map2k1 | Rat | cumene | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [cumene co-treated with KRAS gene mutant form] results in increased expression of MAP2K1 mRNA; [cumene more ... | CTD | PMID:18648096 |
Map2k1 | Rat | curcumin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of more ... | CTD | PMID:21810436 |
Map2k1 | Rat | cycloheximide | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cycloheximide results in increased expression of MAP2K1 mRNA] | CTD | PMID:23237828 |
Map2k1 | Rat | cycloheximide | increases activity | ISO | Map2k1 (Mus musculus) | 6480464 | Cycloheximide results in increased activity of MAP2K1 protein | CTD | PMID:23237828 |
Map2k1 | Rat | cyclosporin A | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MAP2K1 mRNA | CTD | PMID:25562108 |
Map2k1 | Rat | cyclosporin A | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:32152650 |
Map2k1 | Rat | D-mannitol | multiple interactions | EXP | | 6480464 | Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:16510265 |
Map2k1 | Rat | dabrafenib | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | dabrafenib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:38641160 |
Map2k1 | Rat | dabrafenib | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | decabromobiphenyl ether inhibits the reaction [dabrafenib results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:38641160 |
Map2k1 | Rat | daunorubicin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [Daunorubicin results in decreased expression of SP1 protein]; MAP2K1 protein more ... | CTD | PMID:34963561 |
Map2k1 | Rat | decabromodiphenyl ether | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in increased phosphorylation of MAP2K1 protein | CTD | PMID:38641160 |
Map2k1 | Rat | decabromodiphenyl ether | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | decabromobiphenyl ether inhibits the reaction [dabrafenib results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:38641160 |
Map2k1 | Rat | deguelin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | deguelin metabolite results in decreased expression of MAP2K1 protein; deguelin results in decreased expression of more ... | CTD | PMID:19139008|PMID:19336726 |
Map2k1 | Rat | deoxycholic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:32152650 |
Map2k1 | Rat | dexamethasone | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K1 protein]; Mifepristone inhibits more ... | CTD | PMID:10807665 |
Map2k1 | Rat | dexamethasone | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of MAP2K1 mRNA | CTD | PMID:21041162 |
Map2k1 | Rat | diarsenic trioxide | decreases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased activity of MAP2K1 protein | CTD | PMID:11304686 |
Map2k1 | Rat | diarsenic trioxide | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MAP2K1 mRNA | CTD | PMID:22521957 |
Map2k1 | Rat | diarsenic trioxide | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:20592496 |
Map2k1 | Rat | diarsenic trioxide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of more ... | CTD | PMID:20615082 |
Map2k1 | Rat | diarsenic trioxide | decreases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:28454374 |
Map2k1 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MAP2K1 mRNA | CTD | PMID:21266533 |
Map2k1 | Rat | dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of MAP2K1 mRNA | CTD | PMID:18636392 |
Map2k1 | Rat | dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of MAP2K1 mRNA | CTD | PMID:18636392 |
Map2k1 | Rat | dieldrin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Dieldrin results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
Map2k1 | Rat | diethylstilbestrol | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of MAP2K1 mRNA | CTD | PMID:15766595 |
Map2k1 | Rat | diethylstilbestrol | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of MAP2K1 mRNA | CTD | PMID:16636312|PMID:25575267 |
Map2k1 | Rat | dimethyl sulfoxide | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide results in increased expression of MAP2K1 mRNA | CTD | PMID:31265865 |
Map2k1 | Rat | dimethyl sulfoxide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | cucurbitacin IIa inhibits the reaction [Dimethyl Sulfoxide results in increased expression of MAP2K1 mRNA] | CTD | PMID:31265865 |
Map2k1 | Rat | dioxygen | increases response to substance | EXP | | 6480464 | MAP2K1 protein results in increased susceptibility to Oxygen | CTD | PMID:10780954 |
Map2k1 | Rat | dioxygen | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of MAP2K1 mRNA; [Oxygen more ... | CTD | PMID:32992648 |
Map2k1 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of more ... | CTD | PMID:32076005 |
Map2k1 | Rat | diquat | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Diquat results in increased expression of MAP2K1 protein | CTD | PMID:36851058 |
Map2k1 | Rat | disodium selenite | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of MAP2K1 mRNA | CTD | PMID:16705456 |
Map2k1 | Rat | diuron | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Diuron results in decreased expression of MAP2K1 mRNA | CTD | PMID:35967413 |
Map2k1 | Rat | doxorubicin | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Doxorubicin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:17974986 |
Map2k1 | Rat | doxorubicin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of MAP2K1 mRNA | CTD | PMID:29803840 |
Map2k1 | Rat | doxorubicin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] affects the reaction [SOD2 protein results in more ... | CTD | PMID:18594523 |
Map2k1 | Rat | doxorubicin | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Doxorubicin results in increased phosphorylation of MAP2K1 protein | CTD | PMID:17974986 |
Map2k1 | Rat | emodin | multiple interactions | EXP | | 6480464 | Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:15288473 |
Map2k1 | Rat | endosulfan | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Endosulfan results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
Map2k1 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of MAP2K1 mRNA | CTD | PMID:29391264 |
Map2k1 | Rat | escitalopram | increases expression | EXP | | 6480464 | Escitalopram results in increased expression of MAP2K1 mRNA | CTD | PMID:28467792 |
Map2k1 | Rat | estriol | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Estriol results in increased expression of MAP2K1 mRNA | CTD | PMID:25575267 |
Map2k1 | Rat | etacrynic acid | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Ethacrynic Acid results in increased expression of MAP2K1 protein | CTD | PMID:14556662 |
Map2k1 | Rat | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of MAP2K1 mRNA | CTD | PMID:11772933 |
Map2k1 | Rat | ethanol | affects splicing | ISO | Map2k1 (Mus musculus) | 6480464 | Ethanol affects the splicing of MAP2K1 mRNA | CTD | PMID:30319688 |
Map2k1 | Rat | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of MAP2K1 protein | CTD | PMID:23702218 |
Map2k1 | Rat | ethanol | multiple interactions | EXP | | 6480464 | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid inhibits the reaction [Ethanol results in decreased expression of MAP2K1 mRNA] | CTD | PMID:20655511 |
Map2k1 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of MAP2K1 mRNA | CTD | PMID:20655511 |
Map2k1 | Rat | ethyl methanesulfonate | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of MAP2K1 mRNA | CTD | PMID:23649840 |
Map2k1 | Rat | fipronil | decreases activity | ISO | Map2k1 (Mus musculus) | 6480464 | fipronil results in decreased activity of MAP2K1 protein | CTD | PMID:21167920 |
Map2k1 | Rat | flavonoids | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Flavonoids results in decreased expression of MAP2K1 mRNA | CTD | PMID:15465739 |
Map2k1 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MAP2K1 mRNA | CTD | PMID:24136188 |
Map2k1 | Rat | folic acid | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MAP2K1 mRNA | CTD | PMID:25629700 |
Map2k1 | Rat | folic acid | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP2K1 mRNA | CTD | PMID:22206623 |
Map2k1 | Rat | gallic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [Gallic Acid more ... | CTD | PMID:21420233|PMID:27087131|PMID:27634460 |
Map2k1 | Rat | gamma-hexachlorocyclohexane | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
Map2k1 | Rat | geldanamycin | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | CTD | PMID:8816498 |
Map2k1 | Rat | geldanamycin | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | geldanamycin results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:19167484 |
Map2k1 | Rat | genistein | decreases phosphorylation | EXP | | 6480464 | Genistein results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:15781664 |
Map2k1 | Rat | genistein | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Genistein results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19038232 |
Map2k1 | Rat | geraniol | multiple interactions | EXP | | 6480464 | geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA] | CTD | PMID:28428697 |
Map2k1 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:32152650 |
Map2k1 | Rat | glycocholic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:32152650 |
Map2k1 | Rat | glycodeoxycholic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:32152650 |
Map2k1 | Rat | glyphosate | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Glyphosate results in decreased expression of MAP2K1 mRNA | CTD | PMID:31295307 |
Map2k1 | Rat | gold atom | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results more ... | CTD | PMID:27634460 |
Map2k1 | Rat | gold(0) | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results more ... | CTD | PMID:27634460 |
Map2k1 | Rat | GSK-J4 | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | GSK-J4 results in increased expression of MAP2K1 mRNA | CTD | PMID:29301935 |
Map2k1 | Rat | haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of MAP2K1 mRNA | CTD | PMID:15860345 |
Map2k1 | Rat | heparin | multiple interactions | EXP | | 6480464 | Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits more ... | CTD | PMID:14966081 |
Map2k1 | Rat | heptachlor | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Heptachlor results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:15888667 |
Map2k1 | Rat | heptachlor | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Heptachlor results in decreased expression of MAP2K1 protein | CTD | PMID:9704902 |
Map2k1 | Rat | hyaluronic acid | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Hyaluronic Acid analog results in increased phosphorylation of MAP2K1 protein | CTD | PMID:12402308 |
Map2k1 | Rat | hydrogen peroxide | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased activity of MAP2K1 protein | CTD | PMID:15242773|PMID:19038233 |
Map2k1 | Rat | hydrogen peroxide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein affects the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA] | CTD | PMID:26514923 |
Map2k1 | Rat | hydroquinone | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein more ... | CTD | PMID:23288922 |
Map2k1 | Rat | indometacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of MAP2K1 mRNA | CTD | PMID:18299717 |
Map2k1 | Rat | ionomycin | multiple interactions | EXP | | 6480464 | Ionomycin inhibits the reaction [MAP2K1 protein results in increased expression of CALCA mRNA] | CTD | PMID:12574409 |
Map2k1 | Rat | isoprenaline | multiple interactions | EXP | | 6480464 | MAP2K1 protein affects the reaction [Isoproterenol results in increased expression of NPPA mRNA]; MAP2K1 protein more ... | CTD | PMID:10888249 |
Map2k1 | Rat | isoprenaline | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; MAP2K1 protein more ... | CTD | PMID:21177286 |
Map2k1 | Rat | ivermectin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MAP2K1 protein | CTD | PMID:32959892 |
Map2k1 | Rat | ketamine | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity more ... | CTD | PMID:19540866 |
Map2k1 | Rat | lead diacetate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in more ... | CTD | PMID:11861786 |
Map2k1 | Rat | lead(0) | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Lead results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19133285 |
Map2k1 | Rat | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of MAP2K1 mRNA; Lead results in decreased expression of MAP2K1 more ... | CTD | PMID:24960059 |
Map2k1 | Rat | letrozole | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | letrozole results in increased expression of MAP2K1 protein | CTD | PMID:15967659 |
Map2k1 | Rat | lipopolysaccharide | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19010997 |
Map2k1 | Rat | lipopolysaccharide | increases phosphorylation | EXP | | 6480464 | Lipopolysaccharides results in increased phosphorylation of MAP2K1 protein | CTD | PMID:21247645 |
Map2k1 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | MAP2K1 protein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; MAP2K1 protein more ... | CTD | PMID:10469353|PMID:21247645 |
Map2k1 | Rat | lipopolysaccharide | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of MAP2K1 mRNA | CTD | PMID:10975854 |
Map2k1 | Rat | lipopolysaccharide | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAP2K1 protein; Ketamine inhibits the more ... | CTD | PMID:19540866|PMID:21295571|PMID:23362215 |
Map2k1 | Rat | lipopolysaccharide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] | CTD | PMID:18209571 |
Map2k1 | Rat | lipoteichoic acid | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | lipoteichoic acid results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19573522 |
Map2k1 | Rat | lipoteichoic acid | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:19573522 |
Map2k1 | Rat | lithium atom | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein] which more ... | CTD | PMID:19159680 |
Map2k1 | Rat | lithium hydride | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein] which more ... | CTD | PMID:19159680 |
Map2k1 | Rat | lithocholic acid | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein promotes the reaction [Lithocholic Acid results in increased expression of PLAUR mRNA] | CTD | PMID:19782465 |
Map2k1 | Rat | LY294002 | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP3 more ... | CTD | PMID:15850772 |
Map2k1 | Rat | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits more ... | CTD | PMID:12411397 |
Map2k1 | Rat | lycopene | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | lycopene results in increased expression of MAP2K1 mRNA | CTD | PMID:16886892 |
Map2k1 | Rat | Maduramicin | multiple interactions | EXP | | 6480464 | MAP2K1 protein inhibits the reaction [maduramicin results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein more ... | CTD | PMID:29241734 |
Map2k1 | Rat | Maduramicin | decreases response to substance | EXP | | 6480464 | MAP2K1 protein results in decreased susceptibility to maduramicin | CTD | PMID:29241734 |
Map2k1 | Rat | maneb | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of MAP2K1 mRNA; Melatonin inhibits the reaction more ... | CTD | PMID:23963992 |
Map2k1 | Rat | manganese atom | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 |
Map2k1 | Rat | manganese(0) | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 |
Map2k1 | Rat | manganese(II) chloride | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 |
Map2k1 | Rat | melatonin | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of MAP2K1 mRNA] | CTD | PMID:23963992 |
Map2k1 | Rat | mercaptopurine | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Mercaptopurine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
Map2k1 | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of MAP2K1 protein | CTD | PMID:19826936 |
Map2k1 | Rat | methamphetamine | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Methamphetamine results in decreased expression of MAP2K1 protein | CTD | PMID:16192988 |
Map2k1 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of MAP2K1 mRNA | CTD | PMID:30047161 |
Map2k1 | Rat | methylmercury chloride | affects expression | ISO | Map2k1 (Mus musculus) | 6480464 | methylmercuric chloride affects the expression of MAP2K1 mRNA | CTD | PMID:21613230 |
Map2k1 | Rat | methylseleninic acid | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of MAP2K1 mRNA | CTD | PMID:11830524 |
Map2k1 | Rat | methylseleninic acid | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | methylselenic acid results in increased expression of MAP2K1 mRNA | CTD | PMID:12517777 |
Map2k1 | Rat | mifepristone | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of more ... | CTD | PMID:10807665 |
Map2k1 | Rat | mitomycin C | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of more ... | CTD | PMID:21810436 |
Map2k1 | Rat | mono(2-ethylhexyl) phthalate | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:35841924 |
Map2k1 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:35841924 |
Map2k1 | Rat | monosodium L-glutamate | decreases expression | EXP | | 6480464 | Sodium Glutamate results in decreased expression of MAP2K1 mRNA | CTD | PMID:28954212 |
Map2k1 | Rat | myricetin | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | myricetin binds to and results in decreased activity of MAP2K1 protein; myricetin inhibits the reaction more ... | CTD | PMID:17693661 |
Map2k1 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
Map2k1 | Rat | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:18703135 |
Map2k1 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MAP2K1 protein | CTD | PMID:26558463 |
Map2k1 | Rat | N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | EXP | | 6480464 | Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA | CTD | PMID:28428697 |
Map2k1 | Rat | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA] | CTD | PMID:28428697 |
Map2k1 | Rat | N-methyl-N-nitrosourea | multiple interactions | EXP | | 6480464 | Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:12693035 |
Map2k1 | Rat | N-Nitroso-N-methylurethane | multiple interactions | EXP | | 6480464 | Nitrosomethylurethane results in increased phosphorylation of and results in increased activity of MAP2K1 protein | CTD | PMID:12693035 |
Map2k1 | Rat | N-nitrosodiethylamine | affects phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Diethylnitrosamine affects the phosphorylation of MAP2K1 protein | CTD | PMID:24535843 |
Map2k1 | Rat | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of MAP2K1 protein | CTD | PMID:21411721 |
Map2k1 | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of MAP2K1 mRNA | CTD | PMID:24136188 |
Map2k1 | Rat | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of MAP2K1 mRNA | CTD | PMID:22110744 |
Map2k1 | Rat | nitrates | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAP2K1 more ... | CTD | PMID:35964746 |
Map2k1 | Rat | ochratoxin A | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | ochratoxin A results in increased phosphorylation of MAP2K1 protein | CTD | PMID:25002221 |
Map2k1 | Rat | okadaic acid | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of MAP2K1 mRNA | CTD | PMID:38832940 |
Map2k1 | Rat | oxybenzone | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | oxybenzone results in decreased expression of MAP2K1 mRNA | CTD | PMID:39343157 |
Map2k1 | Rat | ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of MAP2K1 mRNA | CTD | PMID:18636392 |
Map2k1 | Rat | ozone | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268|PMID:32992648|PMID:35430440 |
Map2k1 | Rat | p-menthan-3-ol | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Menthol results in decreased expression of MAP2K1 mRNA | CTD | PMID:26760959 |
Map2k1 | Rat | paclitaxel | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] affects the reaction [SOD2 protein results in more ... | CTD | PMID:18098270|PMID:18594523 |
Map2k1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MAP2K1 mRNA | CTD | PMID:33387578 |
Map2k1 | Rat | paraquat | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of MAP2K1 mRNA; Melatonin inhibits the reaction more ... | CTD | PMID:23963992 |
Map2k1 | Rat | PD 0325901 | multiple interactions | EXP | | 6480464 | mirdametinib inhibits the reaction [polyphyllin I inhibits the reaction [Dietary Fats results in decreased expression more ... | CTD | PMID:36120828 |
Map2k1 | Rat | pentachlorophenol | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of MAP2K1 mRNA | CTD | PMID:23892564 |
Map2k1 | Rat | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of MAP2K1 mRNA | CTD | PMID:20136073 |
Map2k1 | Rat | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MAP2K1 mRNA | CTD | PMID:19162173 |
Map2k1 | Rat | perifosine | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein mutant form results in decreased activity of [perifosine co-treated with Butyrates]; MAP2K1 protein more ... | CTD | PMID:15781658 |
Map2k1 | Rat | phenylephrine | multiple interactions | EXP | | 6480464 | MAP2K1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MAP2K1 protein more ... | CTD | PMID:10888249 |
Map2k1 | Rat | PhIP | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased phosphorylation of MAP2K1 protein | CTD | PMID:22307971 |
Map2k1 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in more ... | CTD | PMID:11861786|PMID:16945329|PMID:20479004 |
Map2k1 | Rat | phorbol 13-acetate 12-myristate | increases activity | ISO | Map2k1 (Mus musculus) | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein | CTD | PMID:17693661|PMID:18767048|PMID:8816498 |
Map2k1 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | 3,5,3',4',5'-pentahydroxy-stilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein]; geldanamycin inhibits more ... | CTD | PMID:17693661|PMID:18767048|PMID:8816498 |
Map2k1 | Rat | phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein | CTD | PMID:20479004 |
Map2k1 | Rat | prednisone | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Prednisone results in decreased expression of MAP2K1 mRNA | CTD | PMID:38439560 |
Map2k1 | Rat | propiconazole | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | propiconazole results in increased expression of MAP2K1 mRNA | CTD | PMID:21278054 |
Map2k1 | Rat | propofol | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:19573522 |
Map2k1 | Rat | prostaglandin F2alpha | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Dinoprost results in increased phosphorylation of MAP2K1 protein | CTD | PMID:24333336 |
Map2k1 | Rat | prostaglandin F2alpha | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Dinoprost results in increased phosphorylation of MAP2K1 protein]; SRT1720 inhibits the more ... | CTD | PMID:24333336 |
Map2k1 | Rat | purine-6-thiol | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Mercaptopurine results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:12697733 |
Map2k1 | Rat | pyocyanine | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Pyocyanine results in increased phosphorylation of MAP2K1 protein | CTD | PMID:24015256 |
Map2k1 | Rat | quercetin | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with Quercetin] results in increased expression of MAP2K1 mRNA | CTD | PMID:27514524 |
Map2k1 | Rat | quercetin | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Quercetin binds to and results in decreased activity of MAP2K1 protein | CTD | PMID:18245498 |
Map2k1 | Rat | quinoline | decreases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | quinoline results in decreased activity of MAP2K1 protein | CTD | PMID:18393446 |
Map2k1 | Rat | quinomethionate | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | quinomethionate affects the expression of MAP2K1 mRNA | CTD | PMID:15387888 |
Map2k1 | Rat | reactive oxygen species | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in more ... | CTD | PMID:16945329 |
Map2k1 | Rat | resveratrol | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | resveratrol results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:16761963 |
Map2k1 | Rat | resveratrol | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Dinoprost results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:24333336 |
Map2k1 | Rat | resveratrol | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [resveratrol results in decreased expression of XRCC1 protein] | CTD | PMID:26046675 |
Map2k1 | Rat | resveratrol | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | resveratrol results in increased expression of MAP2K1 mRNA | CTD | PMID:12154049 |
Map2k1 | Rat | resveratrol | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | resveratrol results in increased activity of MAP2K1 protein | CTD | PMID:15615701 |
Map2k1 | Rat | resveratrol | decreases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | resveratrol results in decreased activity of MAP2K1 protein | CTD | PMID:15698585 |
Map2k1 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of MAP2K1 protein | CTD | PMID:35544339 |
Map2k1 | Rat | rottlerin | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | rottlerin results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:15949478 |
Map2k1 | Rat | SCH772984 | increases phosphorylation | EXP | | 6480464 | SCH772984 results in increased phosphorylation of MAP2K1 protein | CTD | PMID:28087833 |
Map2k1 | Rat | serpentine asbestos | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Asbestos, Serpentine affects the expression of MAP2K1 mRNA | CTD | PMID:24160326 |
Map2k1 | Rat | sirolimus | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of MAP2K1 protein; [7-hydroxystaurosporine co-treated with Sirolimus] more ... | CTD | PMID:15767555 |
Map2k1 | Rat | sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein]; Sirolimus inhibits more ... | CTD | PMID:12411397 |
Map2k1 | Rat | sodium arsenite | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [sodium arsenite results in increased phosphorylation of MAP2K1 protein]; [[sodium arsenite more ... | CTD | PMID:10564177|PMID:11943669|PMID:21642427|PMID:39836092 |
Map2k1 | Rat | sodium arsenite | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MAP2K1 mRNA | CTD | PMID:31233874 |
Map2k1 | Rat | sodium arsenite | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | sodium arsenite results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11943669 |
Map2k1 | Rat | sodium arsenite | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MAP2K1 mRNA | CTD | PMID:24431212|PMID:38568856 |
Map2k1 | Rat | sodium arsenite | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MAP2K1 mRNA | CTD | PMID:12016162 |
Map2k1 | Rat | sodium arsenite | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of MAP2K1 mRNA; sodium arsenite affects the expression of MAP2K1 more ... | CTD | PMID:17384772|PMID:29319823|PMID:34032870 |
Map2k1 | Rat | sodium fluoride | increases phosphorylation | EXP | | 6480464 | Sodium Fluoride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:19900517 |
Map2k1 | Rat | sodium fluoride | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Choline inhibits the reaction [Sodium Fluoride results in decreased expression of MAP2K1 mRNA] | CTD | PMID:27664006 |
Map2k1 | Rat | sodium fluoride | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of MAP2K1 mRNA | CTD | PMID:27664006 |
Map2k1 | Rat | sorafenib | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [MAP2K1 protein results in increased phosphorylation of MAPK1 protein] which results in decreased susceptibility to more ... | CTD | PMID:20117835|PMID:21187475 |
Map2k1 | Rat | sorafenib | decreases phosphorylation | EXP | | 6480464 | sorafenib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:17341847 |
Map2k1 | Rat | sorafenib | decreases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | sorafenib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:17341847|PMID:18200035|PMID:19139124 |
Map2k1 | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of MAP2K1 mRNA | CTD | PMID:30047161 |
Map2k1 | Rat | sulfates | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Soot co-treated with Sulfates] affects the methylation of MAP2K1 promoter | CTD | PMID:25395096 |
Map2k1 | Rat | sulindac sulfide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK1 protein]; MAP2K1 more ... | CTD | PMID:15548677|PMID:16079301 |
Map2k1 | Rat | sulindac sulfone | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein]; MAP2K1 more ... | CTD | PMID:15548677 |
Map2k1 | Rat | sumatriptan | multiple interactions | EXP | | 6480464 | [Sumatriptan results in increased abundance of Calcium] inhibits the reaction [MAP2K1 protein results in increased more ... | CTD | PMID:12574409 |
Map2k1 | Rat | sunitinib | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MAP2K1 mRNA | CTD | PMID:31533062 |
Map2k1 | Rat | tamoxifen | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Tamoxifen promotes the reaction [PIN1 protein binds to MAP2K1 protein] | CTD | PMID:20479004 |
Map2k1 | Rat | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of MAP2K1 protein modified form | CTD | PMID:17901229 |
Map2k1 | Rat | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of MAP2K1 protein modified form | CTD | PMID:17901229 |
Map2k1 | Rat | teriflunomide | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | teriflunomide inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein] | CTD | PMID:9973483 |
Map2k1 | Rat | testosterone | increases activity | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Testosterone results in increased activity of RAF1 protein] which results in increased activity of MAP2K1 more ... | CTD | PMID:20372086 |
Map2k1 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [FSHB protein co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [Testosterone promotes the reaction [RAF1 results in more ... | CTD | PMID:21177760 |
Map2k1 | Rat | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of MAP2K1 mRNA | CTD | PMID:17805973 |
Map2k1 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MAP2K1 mRNA | CTD | PMID:31150632 |
Map2k1 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP2K1 mRNA] | CTD | PMID:31150632 |
Map2k1 | Rat | tetrachloromethane | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | Silymarin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:32956689 |
Map2k1 | Rat | tetrachloromethane | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased phosphorylation of MAP2K1 protein | CTD | PMID:32956689 |
Map2k1 | Rat | Theaflavin 3,3'-digallate | decreases expression | EXP | | 6480464 | theaflavin-3,3'-digallate results in decreased expression of MAP2K1 mRNA; theaflavin-3,3'-digallate results in decreased expression of MAP2K1 more ... | CTD | PMID:32964953 |
Map2k1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MAP2K1 mRNA | CTD | PMID:34492290 |
Map2k1 | Rat | thiram | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Thiram results in increased expression of MAP2K1 mRNA | CTD | PMID:38568856 |
Map2k1 | Rat | titanium dioxide | increases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | titanium dioxide analog results in increased phosphorylation of MAP2K1 protein | CTD | PMID:25111187 |
Map2k1 | Rat | titanium dioxide | decreases methylation | ISO | Map2k1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MAP2K1 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 |
Map2k1 | Rat | toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of MAP2K1 mRNA | CTD | PMID:21827849 |
Map2k1 | Rat | toosendanin | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | toosendanin results in decreased expression of MAP2K1 protein modified form | CTD | PMID:23111283 |
Map2k1 | Rat | trametinib | decreases response to substance | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein mutant form results in decreased susceptibility to trametinib | CTD | PMID:29768711 |
Map2k1 | Rat | trametinib | decreases phosphorylation | ISO | Map2k1 (Mus musculus) | 6480464 | trametinib results in decreased phosphorylation of MAP2K1 protein | CTD | PMID:37116855 |
Map2k1 | Rat | trametinib | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [MAP2K1 protein mutant form results in decreased susceptibility to trametinib] inhibits the reaction [trametinib results more ... | CTD | PMID:29768711 |
Map2k1 | Rat | trans-anethole | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein] | CTD | PMID:10871845 |
Map2k1 | Rat | trichostatin A | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein mutant form results in decreased activity of [perifosine co-treated with trichostatin A] | CTD | PMID:15781658 |
Map2k1 | Rat | trichostatin A | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | trichostatin A affects the expression of MAP2K1 mRNA | CTD | PMID:28542535 |
Map2k1 | Rat | trimethyltin | increases expression | ISO | Map2k1 (Mus musculus) | 6480464 | trimethyltin results in increased expression of MAP2K1 mRNA | CTD | PMID:20833246 |
Map2k1 | Rat | triphenyl phosphate | affects expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MAP2K1 mRNA | CTD | PMID:37042841 |
Map2k1 | Rat | troglitazone | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | MAP2K1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA] | CTD | PMID:16079301 |
Map2k1 | Rat | tyrphostin AG 1478 | multiple interactions | EXP | | 6480464 | RTKI cpd inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAP2K1 protein] | CTD | PMID:16269455 |
Map2k1 | Rat | urethane | increases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | Urethane results in increased expression of MAP2K1 mRNA | CTD | PMID:28818685 |
Map2k1 | Rat | vanadyl sulfate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K1 protein]; MRAS mutant more ... | CTD | PMID:10564177|PMID:11943669 |
Map2k1 | Rat | vanadyl sulfate | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | vanadyl sulfate results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11943669 |
Map2k1 | Rat | vorinostat | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | [Bortezomib co-treated with vorinostat] results in decreased expression of MAP2K1 protein; MAP2K1 protein mutant form more ... | CTD | PMID:12893773|PMID:15781658 |
Map2k1 | Rat | vorinostat | decreases expression | ISO | MAP2K1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of MAP2K1 protein | CTD | PMID:12893773 |
Map2k1 | Rat | wogonin | multiple interactions | ISO | Map2k1 (Mus musculus) | 6480464 | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAP2K1 more ... | CTD | PMID:23362215 |
Map2k1 | Rat | zearalenone | decreases expression | ISO | Map2k1 (Mus musculus) | 6480464 | Zearalenone results in decreased expression of MAP2K1 protein | CTD | PMID:36252740 |
Map2k1 | Rat | zinc atom | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:35841924 |
Map2k1 | Rat | zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:35841924 |
Map2k1 | Rat | zinc sulfate | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAP2K1 protein]; MRAS mutant more ... | CTD | PMID:10564177|PMID:11943669 |
Map2k1 | Rat | zinc sulfate | increases phosphorylation | ISO | MAP2K1 (Homo sapiens) | 6480464 | Zinc Sulfate results in increased phosphorylation of MAP2K1 protein | CTD | PMID:11943669 |
Map2k1 | Rat | zinc(0) | multiple interactions | ISO | MAP2K1 (Homo sapiens) | 6480464 | Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:35841924 |
Map2k1 | Rat | zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of MAP2K1 protein] | CTD | PMID:35841924 |